Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy

Michael H. Antoni*, Adam W. Carrico, Ron E. Durán, Susan Spitzer, Frank Penedo, Gail Ironson, Mary Ann Fletcher, Nancy Klimas, Neil Schneiderman

*Corresponding author for this work

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

OBJECTIVE: Human Immunodeficiency Virus (HIV)-positive individuals treated with highly active antiretroviral therapy (HAART) may experience psychological burdens and negative mood states, which could impair their ability to derive maximum benefits from their medical treatment. We tested whether a cognitive behavioral stress management (CBSM) intervention in combination with antiretroviral medication adherence training (MAT) from a clinical pharmacist influences HIV viral load more than MAT alone. METHODS: HIV-positive men who have sex with men were randomized to either a 10-week CBSM + MAT intervention (n = 76) or a MAT-Only condition (n = 54). Data were collected at baseline immediately following the 10-week intervention period, at 9 months postrandomization, and at 15 months postrandomization. RESULTS: We found no differences in HIV viral load among the 130 men randomized. However, in the 101 men with detectable viral load at baseline, those randomized to CBSM + MAT (n = 61) displayed reductions of 0.56 log10 units in HIV viral load over a 15-month period after controlling for medication adherence. Men in the MAT-Only condition (n = 40) showed no change. Decreases in depressed mood during the intervention period explained the effect of CBSM + MAT on HIV viral load reduction over the 15 months. CONCLUSIONS: A time-limited CBSM + MAT intervention that modulates depressed mood may enhance the effects of HAART on suppression of HIV viral load in HIV+ men with detectable plasma levels.

Original languageEnglish (US)
Pages (from-to)143-151
Number of pages9
JournalPsychosomatic Medicine
Volume68
Issue number1
DOIs
StatePublished - Jan 1 2006

Fingerprint

Medication Adherence
Highly Active Antiretroviral Therapy
Viral Load
Randomized Controlled Trials
HIV
Sexual Minorities
Aptitude
Pharmacists
Psychology

Keywords

  • Depression
  • HIV viral load
  • HIV/AIDS
  • Intervention

ASJC Scopus subject areas

  • Applied Psychology
  • Psychiatry and Mental health

Cite this

Antoni, Michael H. ; Carrico, Adam W. ; Durán, Ron E. ; Spitzer, Susan ; Penedo, Frank ; Ironson, Gail ; Fletcher, Mary Ann ; Klimas, Nancy ; Schneiderman, Neil. / Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. In: Psychosomatic Medicine. 2006 ; Vol. 68, No. 1. pp. 143-151.
@article{7d6df78593244ec5a4a520e69f4c543f,
title = "Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy",
abstract = "OBJECTIVE: Human Immunodeficiency Virus (HIV)-positive individuals treated with highly active antiretroviral therapy (HAART) may experience psychological burdens and negative mood states, which could impair their ability to derive maximum benefits from their medical treatment. We tested whether a cognitive behavioral stress management (CBSM) intervention in combination with antiretroviral medication adherence training (MAT) from a clinical pharmacist influences HIV viral load more than MAT alone. METHODS: HIV-positive men who have sex with men were randomized to either a 10-week CBSM + MAT intervention (n = 76) or a MAT-Only condition (n = 54). Data were collected at baseline immediately following the 10-week intervention period, at 9 months postrandomization, and at 15 months postrandomization. RESULTS: We found no differences in HIV viral load among the 130 men randomized. However, in the 101 men with detectable viral load at baseline, those randomized to CBSM + MAT (n = 61) displayed reductions of 0.56 log10 units in HIV viral load over a 15-month period after controlling for medication adherence. Men in the MAT-Only condition (n = 40) showed no change. Decreases in depressed mood during the intervention period explained the effect of CBSM + MAT on HIV viral load reduction over the 15 months. CONCLUSIONS: A time-limited CBSM + MAT intervention that modulates depressed mood may enhance the effects of HAART on suppression of HIV viral load in HIV+ men with detectable plasma levels.",
keywords = "Depression, HIV viral load, HIV/AIDS, Intervention",
author = "Antoni, {Michael H.} and Carrico, {Adam W.} and Dur{\'a}n, {Ron E.} and Susan Spitzer and Frank Penedo and Gail Ironson and Fletcher, {Mary Ann} and Nancy Klimas and Neil Schneiderman",
year = "2006",
month = "1",
day = "1",
doi = "10.1097/01.psy.0000195749.60049.63",
language = "English (US)",
volume = "68",
pages = "143--151",
journal = "Psychosomatic Medicine",
issn = "0033-3174",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. / Antoni, Michael H.; Carrico, Adam W.; Durán, Ron E.; Spitzer, Susan; Penedo, Frank; Ironson, Gail; Fletcher, Mary Ann; Klimas, Nancy; Schneiderman, Neil.

In: Psychosomatic Medicine, Vol. 68, No. 1, 01.01.2006, p. 143-151.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy

AU - Antoni, Michael H.

AU - Carrico, Adam W.

AU - Durán, Ron E.

AU - Spitzer, Susan

AU - Penedo, Frank

AU - Ironson, Gail

AU - Fletcher, Mary Ann

AU - Klimas, Nancy

AU - Schneiderman, Neil

PY - 2006/1/1

Y1 - 2006/1/1

N2 - OBJECTIVE: Human Immunodeficiency Virus (HIV)-positive individuals treated with highly active antiretroviral therapy (HAART) may experience psychological burdens and negative mood states, which could impair their ability to derive maximum benefits from their medical treatment. We tested whether a cognitive behavioral stress management (CBSM) intervention in combination with antiretroviral medication adherence training (MAT) from a clinical pharmacist influences HIV viral load more than MAT alone. METHODS: HIV-positive men who have sex with men were randomized to either a 10-week CBSM + MAT intervention (n = 76) or a MAT-Only condition (n = 54). Data were collected at baseline immediately following the 10-week intervention period, at 9 months postrandomization, and at 15 months postrandomization. RESULTS: We found no differences in HIV viral load among the 130 men randomized. However, in the 101 men with detectable viral load at baseline, those randomized to CBSM + MAT (n = 61) displayed reductions of 0.56 log10 units in HIV viral load over a 15-month period after controlling for medication adherence. Men in the MAT-Only condition (n = 40) showed no change. Decreases in depressed mood during the intervention period explained the effect of CBSM + MAT on HIV viral load reduction over the 15 months. CONCLUSIONS: A time-limited CBSM + MAT intervention that modulates depressed mood may enhance the effects of HAART on suppression of HIV viral load in HIV+ men with detectable plasma levels.

AB - OBJECTIVE: Human Immunodeficiency Virus (HIV)-positive individuals treated with highly active antiretroviral therapy (HAART) may experience psychological burdens and negative mood states, which could impair their ability to derive maximum benefits from their medical treatment. We tested whether a cognitive behavioral stress management (CBSM) intervention in combination with antiretroviral medication adherence training (MAT) from a clinical pharmacist influences HIV viral load more than MAT alone. METHODS: HIV-positive men who have sex with men were randomized to either a 10-week CBSM + MAT intervention (n = 76) or a MAT-Only condition (n = 54). Data were collected at baseline immediately following the 10-week intervention period, at 9 months postrandomization, and at 15 months postrandomization. RESULTS: We found no differences in HIV viral load among the 130 men randomized. However, in the 101 men with detectable viral load at baseline, those randomized to CBSM + MAT (n = 61) displayed reductions of 0.56 log10 units in HIV viral load over a 15-month period after controlling for medication adherence. Men in the MAT-Only condition (n = 40) showed no change. Decreases in depressed mood during the intervention period explained the effect of CBSM + MAT on HIV viral load reduction over the 15 months. CONCLUSIONS: A time-limited CBSM + MAT intervention that modulates depressed mood may enhance the effects of HAART on suppression of HIV viral load in HIV+ men with detectable plasma levels.

KW - Depression

KW - HIV viral load

KW - HIV/AIDS

KW - Intervention

UR - http://www.scopus.com/inward/record.url?scp=33645510627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645510627&partnerID=8YFLogxK

U2 - 10.1097/01.psy.0000195749.60049.63

DO - 10.1097/01.psy.0000195749.60049.63

M3 - Article

VL - 68

SP - 143

EP - 151

JO - Psychosomatic Medicine

JF - Psychosomatic Medicine

SN - 0033-3174

IS - 1

ER -